Metraipolis › archive › dc_5c96cb4f247d
Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: clinical implications and mechanistic insights in type 2 diabetes — Europe PMC PMID:41409228
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41409228
- DOI
- 10.1093/ckj/sfaf351
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T13:36:59.666Z
- SHA-256 of the archived text
2078f8a9fab0fb45e35e2995beacddc30f1cabdf0517ec84a8d5b40e233847a1- Stable URL of this page
https://metraipolis.com/documento/dc_5c96cb4f247d
How to cite
Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: clinical implications and mechanistic insights in type 2 diabetes — Europe PMC PMID:41409228 — Europe PMC (en), https://europepmc.org/article/MED/41409228 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5c96cb4f247d (Metraipolis archive dc_5c96cb4f247d, sha256 2078f8a9fab0fb45e35e2995beacddc30f1cabdf0517ec84a8d5b40e233847a1)
BibTeX
@misc{dc5c96cb4f247d,
title = {Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: clinical implications and mechanistic insights in type 2 diabetes — Europe PMC PMID:41409228},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41409228},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5c96cb4f247d; sha256 2078f8a9fab0fb45e35e2995beacddc30f1cabdf0517ec84a8d5b40e233847a1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41409228. Agents can read the archived copy with the MCP tool read_document.